Gynecology

Saturday, November 24, 2018
GYNECOLOGY

08:30-10:00 SESSION 1
HRT: WHERE WE CAME FROM. WHERE ARE GOING?
ST. James
Capsule Despite the time lapse and the proof to the contrary, we are still dwelling under the shadows of WHI.
Chairpersons Alesandra Graziottin, Italy
Santiago Palacios, Spain
08:30-08:50 Lights and shadows in WHI: A never ending nightmare!
Mark Brincat, Malta
08:50-09:10 HRT for primary prevention?
John Stevenson, UK
09:10-09:35 Selective estrogen receptor modulators
Santiago Palacios, Spain
09:35-10:00 Clinical data and national/international guidelines
Nick Panay, UK
10:00-10:20 COFFEE BREAK AND POSTER VIEWING EXIBITION AREA
10:20-11:50 SESSION 2
HRT PRESCRIBING: MAKING THE SCIENCE APPLICABLE IN THE REAL WORLD
ST. James
Capsule The development of alternatives to HRT to treat vaginal atrophy was accelerated due to the sharp drop in HRT following WHI.
Chairpersons Santiago Palacios, Spain
Mark Brincat, Malta
10:20-10:45 HRT Treatment: Are they all the same
Nick Panay, UK
10:45-11:10 Practical approach to HRT treatment
Louise Newson, UK
11:10-11:50 Debate: Vaginal laser: Erbium or Co2 – which has superior data?
Erbium: Marco Gambacciani, Italy
Co2: Santiago Palacios, Spain
11:50-12:10 BREAK  
12:10-13:40 SESSION 3
Industry Supported Session
ST. James
13:40-14:30 LUNCH BREAK AND POSTER VIEWING EXIBITION AREA
14:30-16:30 SESSION 4
HRT, ESTROGENS AND BREAST CANCER
ST. James
Capsule  
Chairpersons Mark Brincat, Malta
Pierluigi Benedetti Panici, Italy
14:30-14:50 WHO claims, “Estrogens are carcinogenic”. Is this true?
Christian Singer, Austria
14:50-15:15 Can HRT and treatment for menopause be individualized to reduce the incidence of breast cancer?
Mark Brincat, Malta
15:15-15:35 Results of high dose estetrol (E4) treatment in women with advanced breast cancer
Arnd Honig, Germany
15:35-16:00 HRT in cancer survivors
Pierluigi Benedetti Panici, Italy
16:00-16:30 Special countercurrent lecture:
Estrogens for the treatment of Breast Cancer
Herjan Coelingh Bennink, Netherlands
16:30-16:50 COFFEE BREAK AND POSTER VIEWING EXIBITION AREA
16:50-18:20 SESSION 5
PREMATURE OVARIAN INSUFFICIENCY- POI: ADVANCES IN DIAGNOSIS AND MANAGEMENT
ST. James
Capsule Can better understanding help in providing treatment to this frustrating condition?
Chairpersons Nick Panay, UK
Brianna Cloke, UK
16:50-17:10 Does the type of HRT matter in POI?
Monica Mittal, UK
17:10-17:30 100,000 genomes project to unravel etiology of early POI
Brianna Cloke, UK
17:30-17:55 Global POI registry to optimize management
Nick Panay, UK
17:55-18:20 ESHRE POI guidelines: Where to next?
Lisa Webber, UK

Sunday, November 25, 2018
GYNECOLOGY

08:30-10:00 SESSION 6
SLS: THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS
UPDATES ON THE STATE OF THE ART OF MINIMALLY INVASIVE SURGERY TO PRESERVE FERTILITY

ST. James
Capsule  
Chairpersons Pierluigi Benedetti Panici, Italy
Jessica Ybanez Morano, USA
08:30-08:50 The future of minimally invasive surgery for the infertility patient:
Making minimally invasive surgery even less invasive
Mona Orady, USA
08:50-09:10 Surgical management of multi-organ endometriosis and pregnancy outcomes
Theirs Raymondo Soares, USA
09:10-09:35 Radio-frequency ablation: Applications for the preservation of the fibroid uterus
Jessica Ybanez-Morano, USA
09:35-10:00 Dysfunctional uterine bleeding during adolescence
George Creatsas, Greece
10:00-10:20 COFFEE BREAK AND POSTER VIEWING EXIBITION AREA
10:20-11:50 SESSION 7
GENERATING AN HPV DIAGNOSIS IN A SCREENING EVENT
ST. James
Capsule Screening programs need to decide on the technologies employed and usually reply on lab decisions. However, clinicians would benefit from better understanding the subtleties of HPV diagnostics.
Moderator Xavier Bosch, Spain
Participants Jorma Paavonen, Finland
Mario Poljak, Slovenia
Questions Sampling and self-sampling
HPV tests interferences: Blood / Infections
HPV testing: Sensitivity and specificity of the test
The value of type specific testing: Cocktail vs. some types vs. all types
Multiple HPV infections: What do they convey as a predictor of risk?
Co testing: The obvious and the uncertain
Other
11:50-12:10 BREAK  
12:10-13:40 SESSION 8
HPV VACCINES: LIGHTS AND SHADOWS
ST. James
Capsule In Europe, as well as in some developing countries, non-scientific claims of serious adverse events following vaccination are challenging public programs and undermining vaccine confidence.
Moderator Xavier Bosch, Spain
Participants Elmar Joura, Austria
Pauline Paterson, UK
Jorma Paavonen, Finland
Questions What is vaccine hesitancy?
Vaccine safety: The weight of the evidence
The creation and spreading of a rumor: Impact on public programs
Mandatory vaccination
How to confront vaccine hesitancy and anti-vaccine positions
Other
13:40-14:30 LUNCH BREAK AND POSTER VIEWING EXIBITION AREA
14:30-16:30 SESSION 9
PREMATURE OVARIAN FAILURE
ST. James
Capsule  
Chairpersons Mark Brincat, Malta
Marco Gambacianni, Italy
14:30-14:55 Gene involvement in menopause and POI
Joop Laven, Netherlands
14:55-15:20 Women with a family history of PPOI should be offered fertility preservation
Claus Yding Andersen, Belgium
15:20-16:00 Debate: Should androgens be routinely offered to optimize quality of life in menopause?
For: Alessandra Graziottin, Italy
Against: Johannes Bitzer, Switzerland
16:00-16:30 TBA
16:30-16:50 COFFEE BREAK AND POSTER VIEWING EXIBITION AREA
16:50-18:20 SESSION 10
MENOPAUSE AND PERIMENOPAUSE
ST. James
Capsule  
Chairpersons Jenifer Blake, Canada
Johannes Bitzer, Switzerland
16:50-17:10 Menopausal HT: time to re-think, again?
17:10-17:35 Microbiome in menopause or in relation to hormone levels
Gary Ventolini, USA
17:35-17:55 Perimenopausal contraception: What are the options?
TBA
17:55-18:20 Optimizing psychosexual health with perimenopausal contraception
Johannes Bitzer, Switzerland

*The scientific program is subject to change.